International Journal of Clinical Research

Objective To analyze the value of artificial joint replacement and internal fixation in the treatment of osteoporotic unstable intertrochanteric fractures of femur. Methods Patients with osteoporotic unstable intertrochanteric fracture of femur were randomly assigned from January 2022 to December 2023 (n=68). The experimental group underwent artificial joint replacement and the control group underwent internal fixation. Harris score and other indicators were compared. Results The Harris score was 89.32±2.14 in the experimental group and 81.73±3.05 in the control group at the end of treatment. The hip function of the experimental group was better than that of the control group (P < 0.05). The length of stay in bed: the experimental group was better than the control group (P < 0.05). The incidence of complications was as low as 2.94% in the experimental group and 17.65% in the control group. It was found that the incidence of complications in the experimental group was lower (P < 0.05). VAS score: After treatment, the experimental group was lower than (1.52±0.53) points, but the control group was higher than (2.62±0.81) points, and the experimental group was lower (P < 0.05). The rate of excellent and good curative effect was 97.06% in the experimental group, but only 79.41% in the control group. It was found that the data in the experimental group was higher (P < 0.05). Conclusion Arthroplasty for osteoporotic unstable intertrochanteric fracture of femur can result in shorter bed time, faster recovery, lower complication rate, less pain, better efficacy and more obvious improvement in hip function.

Osteoporotic unstable femoral intertrochanteric fracture; Artificial joint replacement; Length of hospital stay; Internal fixation therapy